ArticleOncology research2026

Promoter Hypermethylation-Driven NPHS2 Silencing Promotes Immune Escape and Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.

Shangjian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.